M. Sik

CD 20 as a target for therapy

U. Demkow, J. Bil, M. Winiarska, 2007 .

Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies

F. Magyari, Z. Simon, Á. Illés, 2022, Annals of Hematology.

Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis

E. Berényi, L. Lanczi, L. Csiba, 2021, PloS one.